senktide   Click here for help

GtoPdb Ligand ID: 2127

Synonyms: suc[Asp6,MePhe3]SP(6-11) | suc[Asp6,MePhe3]SP(6-11))
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CSCCC(C(=O)N)NC(=O)C(NC(=O)CNC(=O)C(N(C(=O)C(NC(=O)C(NC(=O)CCC(=O)O)CC(=O)O)Cc1ccccc1)C)Cc1ccccc1)CC(C)C
Isomeric SMILES CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)Cc1ccccc1)C)Cc1ccccc1)CC(C)C
InChI InChI=1S/C40H55N7O11S/c1-24(2)19-28(37(55)45-27(36(41)54)17-18-59-4)44-33(49)23-42-39(57)31(21-26-13-9-6-10-14-26)47(3)40(58)30(20-25-11-7-5-8-12-25)46-38(56)29(22-35(52)53)43-32(48)15-16-34(50)51/h5-14,24,27-31H,15-23H2,1-4H3,(H2,41,54)(H,42,57)(H,43,48)(H,44,49)(H,45,55)(H,46,56)(H,50,51)(H,52,53)/t27-,28-,29-,30-,31-/m0/s1
InChI Key HMHYXLVEFVGOPM-QKUYTOGTSA-N
References
1. Buell G, Schulz MF, Arkinstall SJ, Maury K, Missotten M, Adami N, Talabot F, Kawashima E. (1992)
Molecular characterisation, expression and localisation of human neurokinin-3 receptor.
FEBS Lett, 299 (1): 90-5. [PMID:1312036]
2. Laufer R, Gilon C, Chorev M, Selinger Z. (1986)
Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand.
J Biol Chem, 261 (22): 10257-63. [PMID:2426259]
3. Sarau HM, Feild JA, Ames RS, Foley JJ, Nuthulaganti P, Schmidt DB, Buckley PT, Elshourbagy NA, Brawner ME, Luttmann MA et al.. (2001)
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor.
Eur J Pharmacol, 413 (2-3): 143-50. [PMID:11226387]
4. Sarau HM, Griswold DE, Potts W, Foley JJ, Schmidt DB, Webb EF, Martin LD, Brawner ME, Elshourbagy NA, Medhurst AD et al.. (1997)
Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist.
J Pharmacol Exp Ther, 281 (3): 1303-11. [PMID:9190866]
5. Tian Y, Wu LH, Oxender DL, Chung FZ. (1996)
The unpredicted high affinities of a large number of naturally occurring tachykinins for chimeric NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity.
J Biol Chem, 271 (34): 20250-7. [PMID:8702757]
6. Wormser U, Laufer R, Hart Y, Chorev M, Gilon C, Selinger Z. (1986)
Highly selective agonists for substance P receptor subtypes.
EMBO J, 5 (11): 2805-8. [PMID:2431898]